Sensex drops below 35,000-mark ahead of RBI policy outcome
Mumbai, Oct 5 : The BSE Sensex fell over 300 points Friday, extending its losing run for the third day, ahead of the RBI's bi-monthly policy meet outcome amid weak global cues.
The 30-share index after cracking the 35,000-mark by falling over 335 points to touch a low of 34,833.81, pared some losses to quote 194.44 points, or 0.55 per cent lower at 34,974.72.
It lost 1,356.98 points in the previous two sessions on rupee woes and boiling crude oil prices.
Sectoral indices led by oil and gas, PSU, infrastructure, auto and banking stocks cracked up to 10.27 per cent.
Stocks of state-run oil companies were under selling pressure as the government Thursday announced a Rs 2.50 per litre cut in petrol and diesel prices after it reduced excise duty by Rs 1.50 a litre and asked oil companies to absorb another Re 1.
Shares of BPCL, HPCL and IOC were trading sharply lower by up to 20.50 per cent on nervous selling by investors.
The NSE Nifty also dropped by 90.40 points, or 0.85 per cent, to 10,508.85.
Brokers said investors offloaded their positions, tracking a selloff in global markets as US Treasury surged to multi-year highs on robust economic data and comments from the Federal Reserve, sparking fears of accelerating inflation.
Besides, caution ahead of RBI's monetary policy announcement which expected to hike interest rates by 25 basis points, too, dented sentiments, they added.
Shares of ONGC, Bajaj auto, HUL, ITC, M&M, RIL, Maruti Suzuki, Hero MotoCorp, Adani Ports, HDFC Bank, NTPC, Vedanta, HDFC, HDFC Bank, Tata Steel and Axis Bank tanked up to 11.27 per cent.
On the other hand, Sun Pharma, IndusInd Bank, Tata Motors, Infosys, Yes Bank, PowerGrid, TCS and Kotak Bank bucked market trend, and were trading in the green, rising up to 2 per cent.
Meanwhile, foreign portfolio investors (FPIs) sold shares worth a net of Rs 2,760.63 crore Thursday, while domestic institutional investors (DIIs) bought shares worth a net Rs 1,823.59 crore, provisional data showed.
Among other Asian markets, Japan's Nikkei, Hong Kong's Hang Seng, Strait Times and Taiwan indices fell up to 1.73 per cent.
The US Dow Jones Industrial Average too ended lower Thursday.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
KMC Mangaluru team led by Dr. Haroon files patent for absorbent pads for elderly women
Aims to address urinary incontinence in elderly women
_vb_78.jpeg)
Mangaluru: Kasturba Medical College (KMC) has filed a patent application for “Absorbent Pads” designed to address urinary incontinence among elderly women, a condition that remains largely underreported despite its widespread impact.
Urinary incontinence does not command urgency like a heart attack, nor does it evoke the same collective response as more visible illnesses. However, for those living with it, the burden is constant, intimate, and often isolating.
There is a gradual and often unspoken impact on daily life. It begins with hesitation, declining invitations, avoiding travel, and choosing silence over conversation. Over time, this can lead to withdrawal, where fear of embarrassment starts shaping everyday decisions. For many elderly women, dignity becomes tied to small, often invisible compromises, including limiting outings or adjusting routines.
What makes this condition particularly poignant is not just its prevalence, but its invisibility. It is endured, not expressed. Accepted, not addressed.
It is in this context that the recent innovation assumes importance. The team at KMC, which includes clinicians such as Dr Haroon Hussain, has approached the issue not merely from a technical standpoint but from the perspective of lived experience.
The proposed solution, biodegradable, antimicrobial absorbent pads with improved fluid control and reduced irritation, aims to go beyond basic functionality, addressing comfort, safety, and dignity.
The development also reflects the role of academic institutions in addressing everyday health challenges. When research focuses not only on major diseases but also on conditions that affect quality of life, it reinforces the broader purpose of healthcare.
However, experts note that innovation alone cannot fully address the issue. Urinary incontinence continues to be underreported, often dismissed as an inevitable consequence of ageing. Many women do not seek medical help, not due to a lack of solutions, but because of stigma and discomfort associated with discussing the condition.
This creates a paradox, a widespread issue that is often experienced in isolation.
Medical professionals emphasise that greater awareness and open conversations are essential. Families must learn to speak about such issues without embarrassment. Healthcare providers must create spaces where patients feel heard without judgment.
The significance of this innovation lies not only in its technical aspects but also in what it brings into focus, that even the most private discomforts deserve public attention.
The patent application was filed by a team comprising Dr. Haroon Hussain, Dr. Sameena, Dr. Ritu Raval of Manipal Institute of Technology, Syed Ayaan Hussain Rizvi, and Suzanne Riya Dsouza.
_vb_49.jpeg)
_vb_90.jpeg)